AMI Cardiogenic Shock

ACC/AHA Upgrades mAFP to Class 2a and Downgrades IABP and VA-ECMO to Class 3 in patients with STEMI and Cardiogenic shock

The new Acute Coronary Syndrome (ACS) guidelines downgrade intra-aortic balloon pump (IABP) and venoarterial extracorporeal membrane oxygenation (VA-ECMO) to Class 3 due to no shown benefit, while microaxial intravascular flow pumps (mAFP), Impella®, is now Class 2a in patients with STEMI and severe or refractory cardiogenic shock. 

DanGer Shock RCT

Published in the New England Journal of Medicine, confirms routine use of ImpellaTM Improves Survival in Heart Attack with Shock1

Early Identification of Cardiogenic Shock Improves Outcomes

Timely treatment adhering to a best practice protocol that includes early use of mechanical circulatory support, hemodynamic monitoring and aggressive reduction of inotropes and pressors, can help patients achieve myocardial recovery.5

Best Practice Protocols1-5

For decades cardiogenic shock mortality rates remained at approximately 50%. Starting in 2019, contemporary studies showed that survival can be improved by using best practice protocols.

  • Identify CS early and Impella pre-PCI < 90 minutes
  • Aggressive down-titration of inotropes
  • Identify RV dysfuntion early and support
  • Identify inadequate LV support and escalate
  • Systematic use of RHC to guide therapy
 

Final Results from the National Cardiogenic Shock Initiative (NCSI) Study Demonstrate the Benefit of Early Cardiac Unloading with ImpellaTM

The NCSI study demonstrates a 71% survival to discharge when best practices are used, including placement of an Impella heart pump prior to revascularization.5

 

Heparin-Free Purge Solution

Sodium bicarbonate is the preferred purge solution when heparin is of concern due to HIT or bleeding related to heparin.

Patient Management Resources from the Education Library

 

Assessing and Maintaining the Impella Access Site

Assessing the Impella access site and performing the suggested interventions can help prevent complications and improve patient outcomes.

 

Using the Repositioning Guide with SmartAssist®

This Impella® Skills video demonstrates how to reposition the Impella CP® with SmartAssist® or the Impella 5.5® with SmartAssist® using the Repositioning Guide.

 

Echo for Impella®: How to Measure and Determine Proper Position

Michael Galvin, a clinical educator at Abiomed, discusses how to identify Impella components and measure Impella position using echocardiography.

NPS-1306

This information is intended for use by customers, patients, and healthcare professionals in [region] only. We recognize that the Internet is a global communications medium; however, laws, regulatory requirements, and product information for medical products can vary from country to country. The product information included here may not be appropriate for use outside [region], and the information from other sites you visit may not be appropriate for use in [region].